semaglutide for endometriosis Treating Inflammation with GLP-1s Is this the first disease-modifying

As of March 31, 2024, the FDA received 442 adverse event reports related to compounded semaglutide, including 319 serious cases, 99 hospitalizations, and 7 deaths

This is particularly relevant for patients who have not achieved adequate lipid control with statins alone

Prescription Review If eligible, your provider reviews which medication and dosage are appropriate for your health profile

Tirzepatide works

They are HSA/FSA eligible, making precision weight loss therapy accessible to more patients

Mistake #3: Ignoring Fiber The problem: People focus so hard on protein that they forget about fiber, then wonder why they're constipated for a week